Effect of dose intensity of methotrexate, doxorubicin, and ifosfamide on the prognosis of patients with osteosarcoma

International Journal of Clinical Oncology

Volumn 4, Issue 1, 1999, Pages 36-40

  Uchida, Yoichiro ^a   Ozaki, Toshifumi ^a   Kawai, Akira ^a   Kunisada, Toshiyuki ^a   Dan'ura, Tomoyuki ^a   Naito, Noriko ^a   Inoue, Hajime ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chemotherapy; Dose intensity; Osteosarcoma; Prognosis

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LIMB AMPUTATION; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR LOCALIZATION;

EID: 0033019486     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470050021     Document Type: Article

References (21)

1. Campanacci M, Cervellati G (1975) Osteosarcoma: A review of 345 cases. Ital J Orthop Traumatol 1:5-22
2. Rosen G (1985) Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: A 10 year experience. Orthopedics 8:659-664
3. Bacci G, Picci P, Ferrari S, et al. (1993) Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: Results in 164 patients preoperatively treated with high dose methotrexate followed by cisplatin and doxorubicin. Cancer 72:3227-3238
4. Winkler K, Bielack S, Delling G, et al. (1990) Effect on intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66:1703-1710
5. Bacci G, Picci P, Avella M, et al. (1990) The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: A retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively. J Chemother 2:127-135
6. Kawai A, Sugihara S, Kunisada T, et al. (1996) The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma. Arch Orthop Trauma Surg 115:68-70
7. Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288
8. Uchida A, Myoui A, Araki N, et al. (1997) Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 79:411-415
9. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-120
10. Musculoskeletal Tumor Committee of the Japanese Orthopaedic Association (1995) Bone tumor registration. In: Watanabe S, Tomionaga S, Kakizoe T. Gann monograph on cancer research, cancer treatment and survival. Japan Scientific Societies Press, Tokyo, pp 129-146
11. Isu K, Yamawaki S, Fukuma H, Kawaguchi T (1996) A multiinstitute study of adjuvant chemotherapy for osteosarcoma. J Jpn Orthop Assoc 70:S999
12. Rosen G, Marcove RC, Caparros B, et al. (1979) Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2177
13. Cox DR (1972) Regression models and life-tables. J R Stat Soc [B] 34:187-220
14. Delepine N, Delepine G, Bacci G, et al. (1996) Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Cancer 78:2127-2135
15. Meyers PA, Heller G, Healey J, et al. (1992) Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15
16. Winkler K, Beron G, Kotz R, et al. (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a cooperative German/ Austrian study. J Clin Oncol 2:617-624
17. Rosen G, Caparros B, Huvos AG, et al. (1982) Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230
18. Sæter G, Alvegârd TA, Elomaa I, et al. (1991) Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group Study. J Clin Oncol 9:1766-1775
19. Smith MA, Ungerleider RS, Horowitz ME, Simon R (1991) Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic osteosarcoma and Ewing's sarcoma. J Natl Cancer Inst 83:1460-1470
20. Bacci G, Avella M, Capanna R, et al. (1988) Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: Preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum. Ital J Orthop Traumatol 14:23-39
21. Jaffe N, Frei E, Traggis D, Watts H (1997) Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma. Cancer 39:45-50